Loading company…
Oncoustics develops ultrasound-based liver diagnosis and screening tools.
Founded in 2018 and based in Ontario, Canada, Oncoustics develops AI tools that turn point-of-care ultrasound devices into diagnostic tools for liver and other diseases. Its solutions include a five-minute screening exam and disease-specific apps. In July 2022, it raised USD 5 million in seed funding from Creative Ventures, Saltagen Ventures, NorthSpring Capital Partners, and Pallasite Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in